By jeremyc | April 17, 2017
Previous research has claimed that cannabis oil can be beneficial for people with a rare and severe type of epilepsy, LGS or Lennox-Gastaut syndrome. A new study backs this claim, after it found cannabis oil to show a lot of promise in reducing seizures in patients with LGS. The findings of this study were released just recently.
In LGS, the patient suffers multiple different types of seizures, especially atonic and tonic seizures. In many cases, the intellectual development is impaired. Controlling seizures in LGS often proves difficult and that’s why researchers are looking for other alternatives.
In the latest study, the researchers enrolled 225 LGS patients. The follow-up period was 14 weeks. On average, patients experienced 85 drop seizures in a month. The participants had used an average of 6 drug treatments that hadn’t given satisfactory results. On average, patients were using 3 drugs for epilepsy during the time of the study.
Some participants were administered cannabidiol daily in the dose of 20 mg/kg. Other participants were either given a low dose of this substance (10 mg/kg) daily or a placebo.
Patients who took cannabidiol in the dose of 20 mg/daily recorded an overall reduction of 42 percent in drop seizures, compared to 37 percent in the low dosage group and 17 percent in the placebo group.
Additionally, in case of 40 percent of patients in the higher dosage group, the drop seizures was reduced by 50 percent or more. This figure in the low dosage and placebo group was 36 percent and 15 percent, respectively
Comments are closed.